Literature DB >> 30366765

T-Cell-Intrinsic Receptor Interacting Protein 2 Regulates Pathogenic T Helper 17 Cell Differentiation.

Kenichi Shimada1, Rebecca A Porritt2, Janet L Markman2, Jacqueline Gire O'Rourke3, Daiko Wakita2, Magali Noval Rivas1, Chihiro Ogawa4, Lina Kozhaya5, Gislâine A Martins6, Derya Unutmaz5, Robert H Baloh7, Timothy R Crother1, Shuang Chen1, Moshe Arditi8.   

Abstract

Receptor interacting protein 2 (RIP2) plays a role in sensing intracellular pathogens, but its function in T cells is unclear. We show that RIP2 deficiency in CD4+ T cells resulted in chronic and severe interleukin-17A-mediated inflammation during Chlamydia pneumoniae lung infection, increased T helper 17 (Th17) cell formation in lungs of infected mice, accelerated atherosclerosis, and more severe experimental autoimmune encephalomyelitis. While RIP2 deficiency resulted in reduced conventional Th17 cell differentiation, it led to significantly enhanced differentiation of pathogenic (p)Th17 cells, which was dependent on RORα transcription factor and interleukin-1 but independent of nucleotide oligomerization domain (NOD) 1 and 2. Overexpression of RIP2 resulted in suppression of pTh17 cell differentiation, an effect mediated by its CARD domain, and phenocopied by a cell-permeable RIP2 CARD peptide. Our data suggest that RIP2 has a T cell-intrinsic role in determining the balance between homeostatic and pathogenic Th17 cell responses.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chlamydia pneumoniae; IL-17; RIP2; RORα; Th17; atherosclerosis; chronic inflammation

Mesh:

Substances:

Year:  2018        PMID: 30366765      PMCID: PMC6260980          DOI: 10.1016/j.immuni.2018.08.022

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  46 in total

Review 1.  Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions.

Authors:  Dhavalkumar D Patel; Vijay K Kuchroo
Journal:  Immunity       Date:  2015-12-15       Impact factor: 31.745

2.  Modulation of Nod2-dependent NF-kappaB signaling by the actin cytoskeleton.

Authors:  Sylvie Legrand-Poels; Gaelle Kustermans; Françoise Bex; Elisabeth Kremmer; Thomas A Kufer; Jacques Piette
Journal:  J Cell Sci       Date:  2007-03-13       Impact factor: 5.285

3.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

4.  Chlamydophila pneumoniae re-infection triggers the production of IL-17A and IL-17E, important regulators of airway inflammation.

Authors:  Tímea Mosolygó; József Korcsik; Emese Petra Balogh; Ildikó Faludi; Dezső P Virók; Valéria Endrész; Katalin Burián
Journal:  Inflamm Res       Date:  2013-02-06       Impact factor: 4.575

5.  Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation.

Authors:  Astrid A Ruefli-Brasse; Wyne P Lee; Stephen Hurst; Vishva M Dixit
Journal:  J Biol Chem       Date:  2003-11-24       Impact factor: 5.157

6.  RIP2 is required for NOD signaling but not for Th1 cell differentiation and cellular allograft rejection.

Authors:  T Fairhead; D Lian; M L McCully; B Garcia; R Zhong; J Madrenas
Journal:  Am J Transplant       Date:  2008-06       Impact factor: 8.086

7.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

8.  Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling.

Authors:  Kamran Ghoreschi; Arian Laurence; Xiang-Ping Yang; Cristina M Tato; Mandy J McGeachy; Joanne E Konkel; Haydeé L Ramos; Lai Wei; Todd S Davidson; Nicolas Bouladoux; John R Grainger; Qian Chen; Yuka Kanno; Wendy T Watford; Hong-Wei Sun; Gérard Eberl; Ethan M Shevach; Yasmine Belkaid; Daniel J Cua; Wanjun Chen; John J O'Shea
Journal:  Nature       Date:  2010-10-21       Impact factor: 49.962

9.  Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.

Authors:  P Ye; F H Rodriguez; S Kanaly; K L Stocking; J Schurr; P Schwarzenberger; P Oliver; W Huang; P Zhang; J Zhang; J E Shellito; G J Bagby; S Nelson; K Charrier; J J Peschon; J K Kolls
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

10.  Effector γδ T Cell Differentiation Relies on Master but Not Auxiliary Th Cell Transcription Factors.

Authors:  Joana Barros-Martins; Nina Schmolka; Diana Fontinha; Marta Pires de Miranda; J Pedro Simas; Ingrid Brok; Cristina Ferreira; Marc Veldhoen; Bruno Silva-Santos; Karine Serre
Journal:  J Immunol       Date:  2016-03-18       Impact factor: 5.422

View more
  9 in total

1.  RICK/RIP2 is a NOD2-independent nodal point of gut inflammation.

Authors:  Tomohiro Watanabe; Kosuke Minaga; Ken Kamata; Toshiharu Sakurai; Yoriaki Komeda; Tomoyuki Nagai; Atsushi Kitani; Masaki Tajima; Ivan J Fuss; Masatoshi Kudo; Warren Strober
Journal:  Int Immunol       Date:  2019-09-18       Impact factor: 4.823

2.  Immune Modulation of Allergic Asthma by Early Pharmacological Inhibition of RIP2.

Authors:  Madelyn H Miller; Michael G Shehat; Justine T Tigno-Aranjuez
Journal:  Immunohorizons       Date:  2020-12-18

3.  RIP2 promotes FcγR-mediated reactive oxygen species production.

Authors:  Michael G Shehat; Omar A Cardona; George F Aranjuez; Mollie W Jewett; Justine T Tigno-Aranjuez
Journal:  J Biol Chem       Date:  2019-05-21       Impact factor: 5.157

Review 4.  RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases.

Authors:  Hajime Honjo; Tomohiro Watanabe; Ken Kamata; Kosuke Minaga; Masatoshi Kudo
Journal:  Front Pharmacol       Date:  2021-04-14       Impact factor: 5.810

5.  Genetic and pharmacological inhibition of the nuclear receptor RORα regulates TH17 driven inflammatory disorders.

Authors:  Ran Wang; Sean Campbell; Mohammed Amir; Sarah A Mosure; Molly A Bassette; Amber Eliason; Mark S Sundrud; Theodore M Kamenecka; Laura A Solt
Journal:  Nat Commun       Date:  2021-01-04       Impact factor: 14.919

6.  Essential Role of the Innate Immune Adaptor RIP2 in the Response to Otitis Media.

Authors:  Arwa Kurabi; Jasmine Lee; Kwang Pak; Anke Leichtle; Allen F Ryan
Journal:  Front Genet       Date:  2022-07-12       Impact factor: 4.772

Review 7.  Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis.

Authors:  Qiong Wang; Yurong Wang; Danyan Xu
Journal:  Front Cardiovasc Med       Date:  2022-09-21

Review 8.  Emerging Role of Dendritic Cell Intervention in the Treatment of Inflammatory Bowel Disease.

Authors:  Donglei Sun; Chenyang Li; Shuang Chen; Xiaolan Zhang
Journal:  Biomed Res Int       Date:  2022-10-10       Impact factor: 3.246

9.  Transcriptional profiling identifies caspase-1 as a T cell-intrinsic regulator of Th17 differentiation.

Authors:  Yajing Gao; Krystin Deason; Aakanksha Jain; Ricardo A Irizarry-Caro; Igor Dozmorov; Laura A Coughlin; Isabella Rauch; Bret M Evers; Andrew Y Koh; Edward K Wakeland; Chandrashekhar Pasare
Journal:  J Exp Med       Date:  2020-04-06       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.